MIT and Recursion release Boltz-2 code and weights

Researchers at MIT and Recursion released Boltz-2, which jointly predicts biomolecular structures and binding affinity. Code and weights were available under the MIT license; reported prediction benchmarks did not themselves establish clinical benefit.